Farnesoid X Receptor Agonism, Acetyl-Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 24 07 2019
accepted: 03 10 2019
entrez: 8 1 2020
pubmed: 8 1 2020
medline: 8 1 2020
Statut: epublish

Résumé

A promising approach for the treatment of nonalcoholic steatohepatitis (NASH) is the inhibition of enhanced hepatic

Identifiants

pubmed: 31909359
doi: 10.1002/hep4.1443
pii: HEP41443
pmc: PMC6939503
doi:

Types de publication

Journal Article

Langues

eng

Pagination

109-125

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States

Informations de copyright

© 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.

Références

Hepatology. 2014 May;59(5):2034-42
pubmed: 24115204
J Hepatol. 1997;26 Suppl 1:13-22
pubmed: 9138124
Aliment Pharmacol Ther. 2018 Mar;47(5):645-656
pubmed: 29333665
Nat Rev Endocrinol. 2014 Aug;10(8):488-98
pubmed: 24821328
Endocr Rev. 2003 Jun;24(3):357-87
pubmed: 12788804
Mol Metab. 2016 Feb 23;5(5):340-351
pubmed: 27110486
Cell Metab. 2017 Sep 5;26(3):576
pubmed: 28877461
Gastroenterology. 2014 Mar;146(3):726-35
pubmed: 24316260
Gastroenterology. 2018 Nov;155(5):1463-1473.e6
pubmed: 30059671
World J Hepatol. 2017 Jun 8;9(16):715-732
pubmed: 28652891
Nat Med. 2015 Feb;21(2):159-65
pubmed: 25559344
J Med Chem. 2017 Dec 28;60(24):9960-9973
pubmed: 29148806
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Cell Metab. 2013 Aug 6;18(2):296-302
pubmed: 23931760
Cell Metab. 2012 Feb 8;15(2):240-6
pubmed: 22326225
Hepatology. 2010 Aug;52(2):774-88
pubmed: 20683968
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5
pubmed: 25865049
Nat Med. 2013 Dec;19(12):1649-54
pubmed: 24185692
Hepatology. 2018 Oct;68(4):1574-1588
pubmed: 29486523
Int J Biol Sci. 2018 Aug 6;14(11):1483-1496
pubmed: 30263000
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5417-22
pubmed: 22427358
Science. 2016 Mar 11;351(6278):1166-71
pubmed: 26965621
J Hepatol. 2011 Sep;55(3):654-659
pubmed: 21172393
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:649-662
pubmed: 29058997
J Clin Invest. 2004 May;113(10):1408-18
pubmed: 15146238
J Clin Invest. 2006 Mar;116(3):817-24
pubmed: 16485039
Hepatol Commun. 2019 May 17;3(8):1085-1097
pubmed: 31388629
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
J Transl Med. 2015 Feb 01;13:41
pubmed: 25638165
Lancet. 2015 Mar 14;385(9972):956-65
pubmed: 25468160
Clin Gastroenterol Hepatol. 2018 Dec;16(12):1983-1991.e3
pubmed: 29705265
Semin Liver Dis. 2016 Feb;36(1):69-86
pubmed: 26870934
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1796-805
pubmed: 26976583
PLoS One. 2012;7(2):e31812
pubmed: 22363740

Auteurs

Berangere Gapp (B)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Marie Jourdain (M)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Pauline Bringer (P)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Benjamin Kueng (B)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Delphine Weber (D)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Arnaud Osmont (A)

Biotherapeutic and Analytical Technologies Novartis Institutes for BioMedical Research Basel Switzerland.

Stefan Zurbruegg (S)

Neurosciences Novartis Institutes for BioMedical Research Basel Switzerland.

Judith Knehr (J)

Chemical Biology and Therapeutics Novartis Institutes for BioMedical Research Basel Switzerland.

Rocco Falchetto (R)

Biotherapeutic and Analytical Technologies Novartis Institutes for BioMedical Research Basel Switzerland.

Guglielmo Roma (G)

Chemical Biology and Therapeutics Novartis Institutes for BioMedical Research Basel Switzerland.

William Dietrich (W)

Disease Area X Novartis Institutes for BioMedical Research Cambridge MA.

Reginald Valdez (R)

Disease Area X Novartis Institutes for BioMedical Research Cambridge MA.

Nicolau Beckmann (N)

Musculoskeletal Diseases Novartis Institutes for BioMedical Research Basel Switzerland.

Florian Nigsch (F)

Chemical Biology and Therapeutics Novartis Institutes for BioMedical Research Basel Switzerland.

Arun J Sanyal (AJ)

Department of Internal Medicine Division of Gastroenterology Virginia Commonwealth University Richmond VA.

Iwona Ksiazek (I)

Disease Area X Novartis Institutes for BioMedical Research Basel Switzerland.

Classifications MeSH